|
|
|
|
|
|
|
|
Blogger's Note: 'individualized? vs nurse-led vs conventional?; abstract does not define 'conventional' nor does trial; view link to trial
trial: A randomised study comparing satisfaction with follow up led by a trained cancer nurse versus conventional medical follow-up after primary treatment for ovarian cancer (UK)
trial: Intervention
1. Conventional medical follow up
2. Follow up care led by a trained cancer nurse
2. Follow up care led by a trained cancer nurse
Objective: The aim of the study was to perform a
preliminary comparison of quality of life (QoL) and patient satisfaction
in individualized nurse-led follow-up versus conventional medical
follow-up in ovarian cancer.
Methods: One hundred twelve women who received a
diagnosis of ovarian, fallopian tube, or peritoneal cancer, completed
primary treatment by surgery alone or with chemotherapy, irrespective of
outcome with regard to remission, and expected survival of more than 3
months. Fifty-seven participants were randomized to individualized
follow-up and 55 patients to conventional follow-up. Well-being was
measured at baseline and at 3, 6, 12, and 24 months after randomization
for QoL (QLQ-C30 [European Organisation for Research and Treatment of
Cancer Core Quality of Life Questionnaire], QLQ-Ov28), the Hospital
Anxiety and Depression Scale (HADS), and a Patient Satisfaction
Questionnaire (PSQ-III). The primary endpoints were the effects of
follow-up on each of the scores (via hierarchical mixed-effects model)
and on relapse-free time (via Cox model). The total cost of follow-up
was compared between each group.
Results: There was evidence for a QoL and patient satisfaction benefit for individualized versus standard follow-up. Hospital Anxiety and Depression Scale data provided no evidence in favor of either treatment. Delivered to protocol individualized follow-up resulted in a delay in the presentation of symptomatic relapse, although the effect on survival in this study is unknown. Cost
was £700 lower on average for the individualized follow-up group, but
the difference was not statistically significant at the 5% level.
Conclusions: Individualized follow-up was superior to
conventional follow-up in 3 of the 4 QoL and patient satisfaction
surveys in this preliminary study. Further prospective studies are
needed in a larger population.
Trial registration number is ISRCTN59149551.
0 comments :
Post a Comment
Your comments?
Note: Only a member of this blog may post a comment.